Indeed, we found that the PI3Ki was able to block the increase in primed state cells seen when we treat with TGFB1 alone (Fig. 4C), suggesting that the TGFB1-mediated effects on priming melanoma cells is dependent on downstream PI3K activity. The gene discussed is TGFB1; the disease is melanoma.